Caffeine Completed Phase 1 Trials for Endotoxaemia Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT00513110A Possible Therapeutic Role for Adenosine During Inflammation